Supply chain safety and efficiency are absolutely critical for radiopharmaceutical production, especially given their time-sensitive nature. Radioactive materials are extremely sensitive and begin to decay within a short period of time, leaving just days between manufacturing and injection. This is concerning for patients in dire need of life-saving radiopharmaceuticals, as current supply chain limitations can force them to wait for more than a month for doses to be manufactured and delivered to the hospital. That’s the problem RLS’s purpose-built production and distribution network will solve by ensuring seamless last-mile delivery of patient-specific doses on a time-sensitive basis.
RLS is also developing partnerships that will help fill the demand for medical isotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu 177), which are currently in very short supply. For more about RLS, visit RLS.Bio.
Ad Statistics
Times Displayed: 109208
Times Visited: 6638 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
About RLS Radiopharmacies
RLS (Radioisotope Life Sciences) owns one of the largest radiopharmacy networks in the U.S., with 31 radiopharmacies across 18 states covering 80% of the population. The company also offers an extensive portfolio of diagnostic and therapeutic radiopharmaceutical products. RLS endeavors to supply the highest quality radiopharmaceuticals in the industry by dispensing 100 percent of injectable unit dose products in clean rooms built to ISO 1644-1 specifications. In support of its commitment to quality, RLS provides tailored solutions and exceptional service to more than 1,500 customers. For more information, please visit www.rls.bio.
Back to HCB News
